Hh&L Acquisition Co (HHLA) Stock Price, News & Analysis

Name: Hh&L Acquisition Co (HHLA) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

HHLA NYSE

Company Description

This page collects what Stock Titan holds for HHLA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

14.6M

Shares outstanding

Latest News

View All

May 9, 2023

+0.10%

DiaCarta Receives Accreditation by the College of American Pathologists (CAP)

April 16, 2023

0.00%

DiaCarta Announces Five Abstracts Accepted for Presentation at AACR Annual Meeting 2023

January 12, 2023

+0.10%

DiaCarta Receives U.S. FDA Emergency Use Authorization for its Monkeypox Test Kit

fda approval

January 5, 2023

+0.15%

DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience

Hh&L Acquisition Co has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include fda approval. View all HHLA news →

SEC Filings

View All

No SEC filings available for HHLA.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months